Feasibility of Transcatheter Arterial Chemoembolization for Hepatic Adenoma

Journal of Vascular and Interventional Radiology

Volumn 18, Issue 7, 2007, Pages 862-867

  Kim, Young Il ^a   Chung, Jin Wook ^b   Park, Jae Hyung ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BLEEDING; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GLYCOGEN STORAGE DISEASE TYPE 1; HEMOSTASIS; HORMONAL THERAPY; HUMAN; LEG EDEMA; LIVER ADENOMA; MALE; PRIORITY JOURNAL; SYMPTOM; TUMOR REGRESSION; TUMOR VOLUME;

ADENOMA; ADOLESCENT; ADULT; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GELATIN SPONGE, ABSORBABLE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MITOMYCIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34250767734     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2007.04.014     Document Type: Article

References (21)

1. Baum O.K., Bookstein J.J., Holtz F., and Klein E.W. Possible association between benign hepatomas and oral contraceptives. Lancet 2 (1973) 926-929
2. Yoshidome H., McMasters K.M., and Edwards M.J. Management issues regarding hepatic adenomatosis. Am Surg 65 (1999) 1070-1076
3. Leborgne J., Lehur P.A., Horeau J.M., et al. Therapeutic problems caused by rupture of large hepatic adenoma with central location: apropos of 3 cases. Chirurgie 116 (1990) 454-460
4. Meirowitz R.F., Tobin K.D., Elias E.G., Iseri O., Pais S.O., and Knodell R.G. Resolution of inferior vena cava syndrome after embolization of a hepatic adenoma. Gastroenterology 99 (1990) 1502-1506
5. Derhy S., Soyer P., Roche A., et al. Unresectable hepatic adenomas: management by selective hepatic artery embolization. Gastroenterol Clin Biol 15 (1991) 424-427
6. Ichikawa T., Federle M.P., Grazioli L., and Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214 (2000) 861-868
7. Howell R.R., Stevenson R.E., Ben-Menachem Y., Phyliky R.L., and Berry D.H. Hepatic adenomata with type 1 glycogen storage disease. JAMA 236 (1976) 1481-1484
8. Labrune P., Trioche P., Duvaltier I., Chevalier P., and Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24 (1997) 276-279
9. Heeringa B., and Sardi A. Bleeding hepatic adenoma: expectant treatment to limit the extent of liver resection. Am Surg 67 (2001) 927-929
10. Edmonson H.A., Reynolds T.B., Henderson B., et al. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 86 (1977) 180-182
11. Ramseur W.L., and Cooper M.R. Asymptomatic liver cell adenomas: another case of resolution after discontinuation of oral contraceptive use. JAMA 239 (1978) 1647-1648
12. Marks W.H., Thompson N., and Appleman H. Failure of hepatic adenomas to regress after discontinuance of oral contraceptives: an association with focal nodular hyperplasia and uterine leiomyoma. Ann Surg 208 (1988) 190-195
13. Cheng P.N., Shin J.S., and Lin X.Z. Hepatic adenoma: an observation from asymptomatic stage to rupture. Hepatogastroenterology 43 (1996) 245-248
14. Colonna J., Olthoff K., Busuttil R., et al. Liver resection for primary neoplasms. Adv Surg 25 (1992) 309-329
15. Nagorney D. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 19 (1995) 13-18
16. Ault G.T., Wren S.M., Ralls P.W., Reynolds T.B., and Stain S.C. Selective management of hepatic adenomas. Am Surg 62 (1996) 825-829
17. Flowers B.F., McBurney R.P., and Vera S.R. Ruptured hepatic adenoma: a spectrum of presentation and treatment. Am Surg 56 (1990) 380-383
18. Lesse T., Farges O., and Bismuth H. Liver cell adenomas: a 12-year surgical experience from a specialist hepatobiliary unit. Ann Surg 208 (1988) 558-564
19. Foster J.H., and Berman M.M. The malignant transformation of liver cell adenomas. Arch Surg 129 (1994) 712-717
20. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
21. Malatack J.J., Finegold D.N., Iwatsuki S., et al. Liver transplantation for type I glycogen storage disease. Lancet 1 (1983) 1073-1075